Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Unicycive Therapeutics (UNCY) Preferred Dividend Payments (2023 - 2024)

Unicycive Therapeutics filings provide 2 years of Preferred Dividend Payments readings, the most recent being $887000.0 for Q2 2024.

  • On a quarterly basis, Preferred Dividend Payments rose 47.1% to $887000.0 in Q2 2024 year-over-year; TTM through Dec 2024 was $1.1 million, a 26.3% increase, with the full-year FY2024 number at $1.1 million, up 26.3% from a year prior.
  • Preferred Dividend Payments hit $887000.0 in Q2 2024 for Unicycive Therapeutics, up from $208000.0 in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $887000.0 in Q2 2024 to a low of $72000.0 in Q3 2023.